Search results
Results From The WOW.Com Content Network
Cannabis in Canada is legal for both recreational and medicinal purposes. Cannabis was originally prohibited in 1923 until medicinal use of cannabis was legalized nationwide under conditions outlined in the Marijuana for Medical Purposes Regulations issued by Health Canada, which regulated medical cannabis effective 30 July 2001, and was later superseded by the Access to Cannabis for Medical ...
Cannabis in Mexico is legal for both recreational and medicinal purposes. It became legal for recreational purposes in June 2021, upon application and issuance of a permit from the health secretariat, COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios). [1]
Marketing Authorisation Application (MAA) is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.
Cannabis (/ ˈ k æ n ə b ɪ s /) is a genus of flowering plants in the family Cannabaceae.The number of species within the genus is disputed. Three species may be recognized: Cannabis sativa, C. indica, and C. ruderalis.
A medical cannabis crop in Australia. Cannabis is a plant used in Australia for recreational, medicinal and industrial purposes. In 2022–23, 41% of Australians over the age of fourteen years had used cannabis in their lifetime and 11.5% had used cannabis in the last 12 months.
Cannabis in Ontario is legal for both medical and recreational purposes. Cannabis in Canada has been legal for medicinal purposes since 2001 under conditions outlined in the Access to Cannabis for Medical Purposes Regulations, [1] issued by Health Canada, while seed, grain, and fibre production are permitted under licence. [2]
The cultivation of industrial hemp in South Carolina dates back to at least the 18th century. In 1733, an act was passed in the colony to encourage the growth of hemp for its "useful manufacture to his Majesty's Royal Navy". [1]
A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.